4//SEC Filing
Long Alison S 4
Accession 0001209191-21-070022
CIK 0001751299other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:18 PM ET
Size
7.7 KB
Accession
0001209191-21-070022
Insider Transaction Report
Form 4
Long Alison S
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-15+300,000→ 300,000 totalExercise: $3.08Exp: 2031-12-14→ Common Stock (300,000 underlying) - Award
Restricted Stock Units
2021-12-15+24,350→ 24,350 total→ Common Stock (24,350 underlying)
Footnotes (3)
- [F1]25% of this option shall vest on December 15, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F3]The restricted stock units shall vest 100% on December 15, 2023.
Documents
Issuer
Kaleido Biosciences, Inc.
CIK 0001751299
Entity typeother
Related Parties
1- filerCIK 0001891712
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:18 PM ET
- Size
- 7.7 KB